CAR T-Cell Innovation
Engineering next-generation T-cells with enhanced tumor-targeting capabilities.
Celyad Oncology USA
Advancing Next-Generation CAR T-Cell Therapies
A clinical-stage biotechnology company focused on developing innovative CAR T-cell therapies designed to improve cancer treatment outcomes for hematological cancers and solid tumors.
Core Focus
Driving innovation across CAR T-cell science
Immuno-Oncology
Harnessing the immune system to fight both hematological cancers and solid tumors.
Clinical Excellence
Rigorous clinical programs conducted under strict regulatory and ethical guidelines.
Join the Fight Against Cancer
We're looking for talented professionals passionate about biotechnology and cancer research.
View Open Positions